A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

Journal of Clinical Psychopharmacology

Volumn 21, Issue 5, 2001, Pages 484-487

  Goff, Donald C ^a,b,j   Leahy, Leslie ^a,b   Berman, Ileana ^b,c   Posever, Thomas ^d,e   Herz, Lawrence ^e,f   Leon, Andrew C ^g   Johnson, Steven A ^h   Lynch, Gary ⁱ  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Taunton State Hospital   (United States)

^d LEMUEL SHATTUCK HOSPITAL   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Freedom Trail Clinic   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; AMPA RECEPTOR; AMPA RECEPTOR AGONIST; CLOZAPINE; PLACEBO;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MEMORY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TASK PERFORMANCE; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; CLOZAPINE; COGNITION; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; PILOT PROJECTS; PIPERIDINES; PSYCHOLOGICAL TESTS; SCHIZOPHRENIA;

EID: 0034796599     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200110000-00005     Document Type: Article

References (17)

1. Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus
2. Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit
3. Facilitative effects of the Ampakine CX516 on short term memory in rats: Correlations with hippocampal neuronal activity
4. Facilitation of glutamate receptors enhances memory
5. Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats
6. Synergistic interactions between ampakines and antipsychotic drugs
7. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia
8. Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia
9. Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia
10. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem
11. Inotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: Effects of schizophrenia
12. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
13. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia
14. Effect size as a measure of symptom-specific drug change in clinical trials
15. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
16. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys